![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ERRATUM article
Front. Pediatr. , 12 February 2024
Sec. Children and Health
Volume 12 - 2024 | https://doi.org/10.3389/fped.2024.1380274
This article is an erratum on:
Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation
An Erratum on
By Degraeuwe E, van der Geest T, Persijn L, Nuytinck L, Raes A, Turner M, Fernandes RM, Vande Walle J, de Wildt SN and IMI2 project conect4children(c4c) consortium, including National Hubs/Networks Belgian Pediatric Clinical Research Network (BPCRN) (Belgium) and Pedmed-L (Netherlands) (2023). Front. Pediatr. 11:1302272. doi: 10.3389/fped.2023.1302272
Due to a production error, the funders “European Union's Horizon 2020 research and innovation programme” and “EFPIA” were erroneously omitted, as well as the disclaimer “This publication reflects the authors’ views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein”.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: pediatric, drug development, networks, metrics, feasibility
Citation: Frontiers Production Office (2024) Erratum: Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation. Front. Pediatr. 12:1380274. doi: 10.3389/fped.2024.1380274
Received: 1 February 2024; Accepted: 1 February 2024;
Published: 12 February 2024.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
© 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.